Bupivacaine HCl 0.5% Injectable Solution
Bupivacaine HCl 0.5% Injectable Solution is a pharmaceutical drug with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Nerve Blocks for Episodic Migraine
Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure
Post Operative Pain Management for ACL Reconstruction
Comparison of Different Approaches for Supraclavicular Block and Their Effects on Diaphragm Muscle Function
Pain Relief After PrimaryTKA
Clinical Trials (7)
Efficacy of Nerve Blocks for Episodic Migraine
Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure
Post Operative Pain Management for ACL Reconstruction
Comparison of Different Approaches for Supraclavicular Block and Their Effects on Diaphragm Muscle Function
Pain Relief After PrimaryTKA
Regional Nasal Block and Dexmedetomidine in Endoscopic Sinus Surgery
Comparison of Infraclavicular And Supraclavicular Block
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7